Ocugen (OCGN) Non Operating Income (2014 - 2026)
Ocugen (OCGN) reported Non Operating Income of -$1.3 million for Q1 2026, down 2158.46% on a YoY basis from $65000.0 in Q1 2025, and down 380.5% quarter-over-quarter from $477000.0 in Q4 2025.
Ocugen (OCGN) Non Operating Income (2014 - 2026) Analysis & Trends
Ocugen has reported Non Operating Income for 13 years, with the latest figure at -$1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 2158.46% year-over-year to -$1.3 million; the trailing twelve-month figure through Mar 2026 stood at -$2.1 million (down 694.62% YoY), and the FY2025 full-year result was -$664000.0, down 574.29% from the prior year.
- Non Operating Income for Q1 2026 stood at -$1.3 million, down from $477000.0 in the prior quarter.
- The five-year high for Non Operating Income was $1.2 million in Q3 2022, with the low at -$1.3 million in Q1 2026.
- Historically, Non Operating Income has averaged $140235.3 across 5 years, with a median of $114000.0 in 2025.
- Annual changes were most pronounced in 2022 — Non Operating Income jumped 10777.78% — and 2026, when it tumbled 2158.46%.
- Ocugen's Non Operating Income stood at $961000.0 in 2022, then tumbled by 42.25% to $555000.0 in 2023, then sank by 208.65% to -$603000.0 in 2024, then jumped by 179.1% to $477000.0 in 2025, then sank by 380.5% to -$1.3 million in 2026.
- The last three Non Operating Income figures came in at -$1.3 million (Q1 2026), $477000.0 (Q4 2025), and -$1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | -1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.34 Mn |
| Dec 31, 2025 | 477,000.00 |
| Sep 30, 2025 | -1.32 Mn |
| Jun 30, 2025 | 114,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | -603,000.00 |
| Sep 30, 2024 | 282,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Mar 31, 2024 | -10,000.00 |
| Dec 31, 2023 | 555,000.00 |
| Sep 30, 2023 | 714,000.00 |
| Jun 30, 2023 | 475,000.00 |
| Mar 31, 2023 | 709,000.00 |
| Dec 31, 2022 | 961,000.00 |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 94,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Dec 31, 2021 | -9,000.00 |
| Sep 30, 2021 | -18,000.00 |
| Jun 30, 2021 | -342,000.00 |